What it is
CJC-1295 is a growth hormone releasing hormone (GHRH) analog and ipamorelin is a selective growth hormone secretagogue. They are studied together because they act on two different receptors.
How it's described to work
The pairing is discussed as a way to support the body's own pulsatile growth hormone release rather than introducing exogenous growth hormone — ipamorelin is noted in research for its selectivity, with minimal effect on cortisol or prolactin.
What research discusses it for
Sleep quality researchBody composition researchRecovery research
Important context
Anything touching the growth hormone axis requires baseline labs and provider oversight. Education only.